AKT1 and pancreatic neoplasm: Akt and ERK have also been shown to promote survival signalling (Middleton et al, 2008), and constitutive or induced activation of ERK and Akt pathways has been previously associated with chemoresistant behaviour of pancreatic cancer cells (Yokoi and Fidler, 2004; Zhao et al, 2006).